Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival

BACKGROUND AND OBJECTIVES: We examined the association between the disease-modifying drugs (DMDs) for multiple sclerosis (MS) and survival in a multiregion population-based study. METHODS: We accessed multiple administrative health databases from 4 Canadian provinces. Persons with MS were identified...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Huah Shin, Zhu, Feng, Kingwell, Elaine, Yao, Shenzhen, Ekuma, Okechukwu, Evans, Charity, Fisk, John D., Marrie, Ruth Ann, Zhao, Yinshan, Tremlett, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210547/
https://www.ncbi.nlm.nih.gov/pubmed/35701187
http://dx.doi.org/10.1212/NXI.0000000000200005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210547/
https://www.ncbi.nlm.nih.gov/pubmed/35701187
http://dx.doi.org/10.1212/NXI.0000000000200005

Ejemplares similares